4.12.2025
3.12.2025
5
Dec
2025
Find more news and events
Suomeksi
In English
The doctoral research covers preclinical studies performed to obtain the comprehensive pharmacokinetic parameters of two important ocular drugs: brinzolamide and dexamethasone.
Beta-2 agonists are bronchodilators commonly used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
The Academy of Finland’s Research Council for Natural Sciences and Engineering has granted 3.5 million euros of funding to new Academy Projects at the University of Eastern Finland.
The project will examine the use of lipid nanoparticles in transporting mRNA into ocular tissues.
The Academy of Finland’s Research Council for Biosciences, Health and the Environment granted more than 5.2 million euros of funding to Academy Projects at the University of Eastern Finland.
The University of Eastern Finland will showcase its expertise in collaboration with Kuopio Health at Radical Health Festival Helsinki 2023, a new pan-European conference bringing together key players in digital health.
The symposium is open to all scientists and clinicians who are interested in brain tumour research. It is free-of-charge for Ph.D. students enrolled in any doctoral programme at UEF, but there are only limited seats available.
The findings and models from this doctoral research can be valuable in the development of more effective treatments for anterior segment ocular diseases.
The lecture topics range from radiation biology to forest planning, and from pharmaceutical policy and brain health to literature and education.
The Academy of Finland’s Research Council for Culture and Society has granted Academy Research Fellow funding to Mirella Miettinen and Armi Mustosmäki.